Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-10598
Eur J Pharmacol 2000 Jul 14;4001:11-7. doi: 10.1016/s0014-2999(00)00395-2.
Show Gene links Show Anatomy links

Stereospecific modulation of GABA(A) receptor function by urocanic acid isomers.

Uusi-Oukari M , Soini SL , Heikkilä J , Koivisto A , Neuvonen K , Pasanen P , Sinkkonen ST , Laihia JK , Jansén CT , Korpi ER .


???displayArticle.abstract???
A deamination product of histidine, urocanic acid, accumulates in the skin of mammals as trans-urocanic acid. Ultraviolet (UV) irradition converts it to the cis-isomer that is an important mediator in UV-induced immunosuppression. We have recently shown that urocanic acid interferes with the agonist binding to GABA(A) receptors. We now report that the effects of urocanic acid on binding of a convulsant ligand (t-butylbicyclo[35S]phosphorothionate) to GABA(A) receptors in brain membrane homogenates are dependent on pH of the incubation medium, the agonistic actions being enhanced at the normal pH of the skin (5.5). Using Xenopus laevis oocytes expressing recombinant rat alpha1beta1gamma2S GABA(A) receptors, the low pH potentiated the direct agonistic action of trans-urocanic acid under two-electrode voltage-clamp, whereas cis-urocanic acid retained its low efficacy both at pH 5.5 and 7.4. The results thus indicate clear differences between urocanic acid isomers in functional activity at one putative receptor site of immunosuppression, the GABA(A) receptor, the presence of which in the skin remains to be demonstrated.

???displayArticle.pubmedLink??? 10913580
???displayArticle.link??? Eur J Pharmacol